DOI: 10.1055/s-00022861

Aktuelle Kardiologie

References

Williams B, MacDonald TM, Morant SV. et al.
Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial.

Lancet 2015;
386: 2059-2068

Download Bibliographical Data

Access:
Access:
Access: